Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Megan H. Pesch, MD, MS

Assistant Professor of Developmental and Behavioral Pediatrics
C.S. Mott Children's Hospital
University of Michigan Medical School
Ann Arbor, Michigan

Disclosures

Megan H. Pesch, MD MS, has the following relevant financial relationships:
Consultant or advisor for: DiaSorin Molecular
Speaker or member of speakers bureau for: DiaSorin Molecular

Natali Aziz, MD, MS

Clinical Associate Professor
Stanford University School of Medicine
Stanford, California

Disclosures

Natali Aziz, MD, MS, has no relevant financial relationships.

Malavika Prabhu, MD

Assistant Professor
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

Malavika Prabhu, MD, has no relevant financial relationships.

Editor

Iwona Misiuta, PhD, MHA

Medical Education Director, Medscape, LLC

Disclosures

Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / CE

Cytomegalovirus and Pregnancy: Risk Reduction Strategies

Authors: Megan H. Pesch, MD, MS; Natali Aziz, MD, MS; Malavika Prabhu, MD
CME / CE Released: 12/29/2022
Valid for credit through: 12/29/2023, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for obstetrics/gynecology specialists, pediatricians, primary care clinicians, nurses, pharmacists, and other healthcare professionals who care for patients at risk for acquiring CMV.

The goal of this activity is for learners to be better able to select appropriate CMV risk reduction strategies prior to and during pregnancy.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Role of prevention of CMV transmission before and during pregnancy

Disclosures

Faculty

Megan H. Pesch, MD, MS

Assistant Professor of Developmental and Behavioral Pediatrics
C.S. Mott Children's Hospital
University of Michigan Medical School
Ann Arbor, Michigan

Disclosures

Megan H. Pesch, MD MS, has the following relevant financial relationships:
Consultant or advisor for: DiaSorin Molecular
Speaker or member of speakers bureau for: DiaSorin Molecular

Natali Aziz, MD, MS

Clinical Associate Professor
Stanford University School of Medicine
Stanford, California

Disclosures

Natali Aziz, MD, MS, has no relevant financial relationships.

Malavika Prabhu, MD

Assistant Professor
Department of Obstetrics and Gynecology
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

Malavika Prabhu, MD, has no relevant financial relationships.

Editor

Iwona Misiuta, PhD, MHA

Medical Education Director, Medscape, LLC

Disclosures

Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape designates this continuing education activity for 0.25 contact hour(s) ( 0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-374-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 4

CME / CE Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Megan H. Pesch, MD, MS

Natali Aziz, MD, MS

Malavika Prabhu, MD

Editor

Iwona Misiuta, PhD, MHA

Compliance Reviewer

Yaisanet Oyola, MD

Peer Reviewer

CME / CE

Cytomegalovirus and Pregnancy: Risk Reduction Strategies

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Megan H. Pesch, MD, MS

Natali Aziz, MD, MS

Malavika Prabhu, MD

Editor

Iwona Misiuta, PhD, MHA

Compliance Reviewer

Yaisanet Oyola, MD

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

For Pharmacists

Instructions for Participation and Credit

Cytomegalovirus and Pregnancy: Risk Reduction Strategies

Learning Feedback Questions